Epidermal growth factor receptor inhibition leads to cellular phenotype correction of DSP ‐mutated keratinocytes
Experimental Dermatology · 2024
DOI: 10.1111/exd.15046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2024. Verfasst von Daniela Andrei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Expertise Center for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Net…. Hauptthemen laut MEDLINE: Desmoplakins, ErbB Receptors, Hair Diseases, Keratoderma, Palmoplantar. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stichting Vlinderkind.
Abstract (Originalsprache)
Desmoplakin (DSP) is a desmosomal component expressed in skin and heart, essential for desmosome stability and intermediate filament connection. Pathogenic variants in the DSP gene encoding DSP, lead to heterogeneous skin, adnexa and heart‐related phenotypes, including skin fragility, woolly hair (WH), palmoplantar keratoderma (PPK) and arrhythmogenic/dilated cardiomyopathy (ACM/DCM). The ambiguity of computer‐based prediction analysis of pathogenicity and effect of DSP variants, indicates a necessity for functional analysis. Here, we report a heterozygous DSP variant that was not previously described, NM_004415.4:c.3337C>T (NM_004415.4(NP_004406.2):p.(Arg1113*)) in a patient with PPK, WH and ACM. RNA and protein analysis revealed ~50% reduction of DSP mRNA and protein expression. Patient's keratinocytes showed fragile cell–cell connections and perinuclear retracted intermediate filaments. Epidermal growth factor receptor (EGFR) is a transmembrane protein expressed in the basal epidermal layer involved in proliferation and differentiation, processes that are disrupted in the development of PPK, and in the regulation of the desmosome. In skin of the abovementioned patient, evident EGFR upregulation was observed. EGFR inhibition in patient's keratinocytes strongly increased DSP expression at the plasma membrane, improved intermediate filament connection with the membrane edges and reduced the cell–cell fragility. This cell phenotypic recovery was due to a translocation of DSP to the plasma membrane together with an increased number of desmosomes. These results indicate a therapeutic potential of EGFR inhibitors for disorders caused by DSP haploinsufficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Expertise Center for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Genetics, Expertise Center for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
ORCID-Profile: Daniela Andrei, Jeroen Bremer, Mathilde C S C Vermeer
Förderung
- Stichting Vlinderkind
Zitieren
APA
Andrei, D., Bremer, J., Kramer, D., Nijenhuis, A. M., van der Molen, M., Diercks, G. F. H., van den Akker, P. C., Vermeer, M. C. S. C., van der Meer, P., & Bolling, M. C. (2024). Epidermal growth factor receptor inhibition leads to cellular phenotype correction of DSP ‐mutated keratinocytes. Experimental Dermatology. https://doi.org/10.1111/exd.15046
Vancouver
Andrei D, Bremer J, Kramer D, Nijenhuis AM, van der Molen M, Diercks GFH, et al. Epidermal growth factor receptor inhibition leads to cellular phenotype correction of DSP ‐mutated keratinocytes. Experimental Dermatology. 2024. doi:10.1111/exd.15046
BibTeX
@article{Andrei2024,
author = {Andrei, Daniela and Bremer, Jeroen and Kramer, Duco and Nijenhuis, Albertine M and van der Molen, Marije and Diercks, Gilles F H and van den Akker, Peter C and Vermeer, Mathilde C S C and van der Meer, Peter and Bolling, Maria C},
title = {Epidermal growth factor receptor inhibition leads to cellular phenotype correction of DSP ‐mutated keratinocytes},
journal = {Experimental Dermatology},
year = {2024},
doi = {10.1111/exd.15046}
}
EUVIMED